# Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage

> **NCT04505514** · PHASE4 · UNKNOWN · sponsor: **University of Malaya** · enrollment: 60 (estimated)

## Conditions studied

- Post Partum Hemorrhage
- Anemia

## Interventions

- **DRUG:** Iron Isomaltoside 1000
- **DRUG:** Placebo
- **DRUG:** Iberet-Folic-500

## Key facts

- **NCT ID:** NCT04505514
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04505514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04505514, "Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04505514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*